SCHEMBL6771024

SCHEMBL6771024

C=CCC1(C(=O)Cl)c2ccccc2-c2ccccc21

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRB P10828 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
PGR P06401 2/20 0.39
APEX1 P27695 1/20 0.39
ALPL P05186 1/20 0.35
GAA P10253 1/20 0.35
ALPG P10696 1/20 0.35
S100A4 P26447 1/20 0.34
KMT2A Q03164 2/20 0.33
ALDH1A1 P00352 3/20 0.33
POLB P06746 2/20 0.33
MEN1 O00255 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
CYP3A4 P08684 1/20 0.33
PDK2 Q15119 1/20 0.32
MAPT P10636 1/20 0.32
CYP1A2 P05177 1/20 0.32
HPGD P15428 1/20 0.32
CYP2C19 P33261 1/20 0.32
TSHR P16473 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5864017 0.84 THRB (0.48) THRBTDP1PGRAPEX1ALPL
Hydrochloric Acid SCHEMBL6771034 0.83 THRB (0.47) THRBTDP1PGRAPEX1ALPL
SCHEMBL11040480 0.78 APEX1 (0.47) THRBTDP1APEX1GAAS100A4
Butane SCHEMBL28645193 0.78 THRB (0.35) THRBTDP1PGRAPEX1KMT2A
SCHEMBL6771031 0.77 PDK2 (0.42) THRBTDP1PGRAPEX1KMT2A
SCHEMBL6649344 0.76 PDK2 (0.40) KMT2AALDH1A1POLBMEN1PDK2
SCHEMBL5864282 0.76 MAPT (0.39) KMT2AALDH1A1MEN1PDK2MAPT
SCHEMBL7595701 0.76 PGR (0.36) THRBTDP1PGRAPEX1ALPL
SCHEMBL6647281 0.75 PDK2 (0.41) THRBTDP1PGRAPEX1ALPL
SCHEMBL6771005 0.74 MTTP (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6821967-B2 AMINES SUCH AS 9-(4-(4-(BENZOTHIAZOL-2-YL)-PIPERAZIN-1-YL)-BUTYL)-9H-FLUORENE-9-CARBOXYLIC ACID (2,2,2-TRIFLUOROETHYL) AMIDE, USED AS MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN ANTAGONISTS, TO PREVENT ATHEROSCLEROSIS OR HYPERLIPEMIA BOEHRINGER INGELHEIM PHARMA KG (DE) 2004-11-23 US disclosed
US-20030166637-A1 Substituted piperazine derivatives, the preparation thereofand their use as medicaments BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) 2003-09-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030166637-A1 Substituted piperazine derivatives, the preparation thereofand their use as medicaments MTTP, CETP, CPT1A THRB 1383/4885TDP1 2302/4885PGR 638/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.